New scaffolds of natural origin as Integrase–LEDGF/p75 interaction inhibitors: Virtual screening and activity assays

European Journal of Medicinal Chemistry
2013.0

Abstract

The disruption of crucial interactions between HIV-1 Integrase and cellular cofactor LEDGF/p75 represents an emerging approach for the design and development of new antiretroviral agents. In this study we report the successful application of a structure-based virtual screening strategy for the discovery of natural hit structures able to inhibit Integrase-LEDGF/p75 interaction. The application of sequential filters (drug-likeness, 3D-pharmacophore mapping, docking, molecular dynamics simulations) yielded a hit list of compounds, out of which 9 were tested in the in vitro AlphaScreen assays and 8 exhibited a detectable inhibition of the interaction between the two proteins. The best inhibitors belong to different chemical classes and could be represent a good starting point for further optimization and structure-activity relationship studies.

Knowledge Graph

Similar Paper

New scaffolds of natural origin as Integrase–LEDGF/p75 interaction inhibitors: Virtual screening and activity assays
European Journal of Medicinal Chemistry 2013.0
Discovery of Inhibitors To Block Interactions of HIV-1 Integrase with Human LEDGF/p75 via Structure-Based Virtual Screening and Bioassays
Journal of Medicinal Chemistry 2012.0
Discovery of novel inhibitors of LEDGF/p75-IN protein–protein interactions
Bioorganic & Medicinal Chemistry 2013.0
Fragment-Based Discovery of 8-Hydroxyquinoline Inhibitors of the HIV-1 Integrase–Lens Epithelium-Derived Growth Factor/p75 (IN–LEDGF/p75) Interaction
Journal of Medicinal Chemistry 2013.0
Discovery and Optimization of Novel Pyrazolopyrimidines as Potent and Orally Bioavailable Allosteric HIV-1 Integrase Inhibitors
Journal of Medicinal Chemistry 2020.0
Discovery of HIV-1 Integrase Inhibitors by Pharmacophore Searching
Journal of Medicinal Chemistry 1997.0
Virtual Screening, Identification, and Biochemical Characterization of Novel Inhibitors of the Reverse Transcriptase of Human Immunodeficiency Virus Type-1
Journal of Medicinal Chemistry 2008.0
Inhibiting HIV-1 integrase by shifting its oligomerization equilibrium
Proceedings of the National Academy of Sciences 2007.0
3-Hydroxypyrimidine-2,4-diones as an Inhibitor Scaffold of HIV Integrase
Journal of Medicinal Chemistry 2011.0
Design, synthesis and biological evaluation of imidazole and oxazole fragments as HIV-1 integrase-LEDGF/p75 disruptors and inhibitors of microbial pathogens
Bioorganic & Medicinal Chemistry 2020.0